tradingkey.logo

Contineum Therapeutics Initiates Patient Dosing in Phase 1b Chronic Pain Trial of PIPE-791

ReutersMar 4, 2025 9:54 PM

- Contineum Therapeutics Inc CTNM.O:

  • CONTINEUM THERAPEUTICS INITIATES PATIENT DOSING IN PHASE 1B CHRONIC PAIN TRIAL OF PIPE-791

  • CONTINEUM THERAPEUTICS INC - TOPLINE DATA FROM PIPE-791 PHASE 1B TRIAL EXPECTED IN EARLY 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

Tradingkey
KeyAI